ArticleFrontiers in oncology2026

Peroxisomal activity drives aggressive bladder cancer phenotypes and reveals erythorbic acid as a potential therapeutic modulator.

Qinghui Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.